HIVE Blockchain Technologies Ltd. (CVE:HIV – Free Report) – Equities researchers at HC Wainwright lifted their Q3 2026 EPS estimates for HIVE Blockchain Technologies in a note issued to investors on Tuesday, December 3rd. HC Wainwright analyst M. Colonnese now forecasts that the company will post earnings per share of $0.07 for the quarter, up from their previous estimate of $0.06. HC Wainwright has a “Strong-Buy” rating on the stock.
Other equities analysts have also issued research reports about the stock. Cantor Fitzgerald raised shares of HIVE Blockchain Technologies to a “strong-buy” rating in a research report on Tuesday, October 29th. Northland Capmk upgraded HIVE Blockchain Technologies to a “strong-buy” rating in a report on Thursday, September 19th.
HIVE Blockchain Technologies Stock Performance
HIVE Blockchain Technologies Ltd. is a services company in the Business Services industry.
Recommended Stories
- Five stocks we like better than HIVE Blockchain Technologies
- Find and Profitably Trade Stocks at 52-Week Lows
- Trinity Capital CEO on Leading Private Credit’s High-Yield Growth
- Following Congress Stock Trades
- Lululemon Surges On Q3 Report: Analysts Step in To Support Market
- The 3 Best Fintech Stocks to Buy Now
- 10 Safe Investments with High Returns
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
